Malignant pericardial effusion.
Burazor I, Imazio M, Markel G, Adler Y.
Cardiology. 2013;124(4):224-32. doi: 10.1159/000348559. Epub 2013 Apr 5.
Neoplastic Pericardial Disease.
Maleszewski JJ, Anavekar NS.
Cardiol Clin. 2017 Nov;35(4):589-600. doi: 10.1016/j.ccl.2017.07.011. Epub 2017 Sep 6.
Secondary malignant lesions of the heart and pericardium in neoplastic disease.
Skhvatsabaja LV.
Oncology. 1986;43(2):103-6. doi: 10.1159/000226344.
Pericardial Involvement in Cancer.
Chahine J, Shekhar S, Mahalwar G, Imazio M, Collier P, Klein A.
Am J Cardiol. 2021 Apr 15;145:151-159. doi: 10.1016/j.amjcard.2020.12.092. Epub 2021 Jan 15.
Cardiac metastases.
Bussani R, De-Giorgio F, Abbate A, Silvestri F.
J Clin Pathol. 2007 Jan;60(1):27-34. doi: 10.1136/jcp.2005.035105. Epub 2006 Nov 10.
The incidence of secondary tumors of the heart and pericardium: a 10-year study.
Mukai K, Shinkai T, Tominaga K, Shimosato Y.
Jpn J Clin Oncol. 1988 Sep;18(3):195-201.
Secondary malignant tumors of the pericardium.
THURBER DL, EDWARDS JE, ACHOR RW.
Circulation. 1962 Aug;26:228-41. doi: 10.1161/01.cir.26.2.228.
Purulent pericarditis.
Kennedy C, McEvoy S.
Ir J Med Sci. 2009 Mar;178(1):97-9. doi: 10.1007/s11845-008-0119-1. Epub 2008 Jan 23.
Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors.
Taguchi S.
Gen Thorac Cardiovasc Surg. 2018 May;66(5):257-262. doi: 10.1007/s11748-018-0912-3. Epub 2018 Mar 28.
A Clinico-Pathologic Approach to the Differential Diagnosis of Pericardial Tumors.
Krywanczyk AR, Tan CD, Rodriguez ER.
Curr Cardiol Rep. 2021 Jul 16;23(9):119. doi: 10.1007/s11886-021-01548-6.
